What is the rate of adverse events with intravenous versus oral N-acetylcysteine in pediatric patients?
Michael E. Mullins, Richard U. Schmidt Jr., Timothy B. JangVolume:
44
Year:
2004
Language:
english
Pages:
2
DOI:
10.1016/j.annemergmed.2004.03.051
File:
PDF, 57 KB
english, 2004